NASDAQCommunication ServicesAdvertising AgenciesSnapshot 2026-07-23
Reading MCHX? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This investment represents a speculative growth bet with a medium confidence level. The current thesis state is cautious, as the company is navigating a volatile management situation and loss-making status.
The market seems to be pricing in elevated risks and a challenging sector backdrop, given MCHX's recent weak financial performance. Expectations may be low, especially after the recent guidance increase, which adds pressure to meet future targets.
Fundamentals are likely to remain weak in the near term, as management has struggled to achieve sequential revenue increases and improve adjusted EBITDA margins. The probability of missing earnings is notable, given the company's smaller size and the high miss rate in its industry.
The long-term thesis hinges on several factors, including the company's ability to maintain credibility after recent guidance changes and the potential impact of Federal Reserve rate cuts. Additionally, positive momentum from sector leaders could provide a favorable lift for MCHX.
Over the next 1 to 3 years, MCHX's performance will depend on its execution and external market conditions. Not investment advice.
The most important moves since the prior daily snapshot.
Our read on the company is unchanged since the prior snapshot.
as of 2026-07-23
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Why it matters: Another miss would show ongoing money problems. This could hurt investor trust.
Confirms:The Q2 earnings report shows results lower than analysts expected.
Disproves:Q2 earnings meet or are better than what analysts expected.
Why it matters: Sequential revenue growth is key to showing recovery after a decline in Q1 2026.
Confirms:Q2 2026 revenue was over $10.6 million. This shows growth from the previous quarter.
Disproves:Q2 2026 revenue was under $10.6 million. This shows a decline from before.
Why it matters: If the sector starts growing again, it could help Marchex's performance. This would signal a potential recovery.
Confirms:Sector revenue growth shows a positive change after being negative.
Disproves:Sector revenue growth is still negative. It may drop even more.
Why it matters: Reaching this target shows the company is making more money. It also shows better efficiency.
Confirms:Q2 2026 Adjusted EBITDA was $1.6 million or more.
Disproves:Q2 2026 Adjusted EBITDA was below $1.6 million. This shows weaker performance.
Why it matters: Guidance for higher revenue in Q3 would signal confidence in growth and product adoption.
Confirms:Q3 2026 revenue guidance reported above Q2 levels.
Disproves:Q3 2026 revenue guidance reported at or below Q2 levels.
